Skip to content

A Study of Questionnaires in Adolescents and Young Adults With Cancer

Psychometric and Linguistic Validation of PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults (15-39) With Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07212166
Enrollment
120
Registered
2025-10-08
Start date
2025-09-30
Completion date
2027-09-30
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents and Young Adults With Cancer

Keywords

PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults, Psychometric and Linguistic Validation

Brief summary

The purpose of this study is to evaluate a questionnaire called PRO-AYA: Patient-Reported Outcomes for Adolescents and Young Adults.

Interventions

OTHERPatient-Reported Outcome Surveys

PRO-AYA , Patient-Reported ECOG PS, EORTC QLQ-C30, Demographic/Clinical Characteristics

OTHERSpanish version of PRO-AYA and the cognitive interview

Revised Spanish PRO-AYA, Demographic/Clinical Characteristics

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
15 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* English- or Spanish proficient o As assessed by two items: How well do you speak English? What is your preferred language for healthcare? * Between the ages of 15-39 * Diagnosed with cancer or the recurrence of a cancer as per clinician report and/or received active treatment for cancer between the ages of 15-39 * Able to complete questionnaires by themselves or with assistance as per self-report * For Cohort 1 ONLY: * 3 months from last treatment without plan to initiate any form of cancer-directed treatment in the next 3 months OR * On chronic cancer-directed therapy for the last 3 months without plan to change cancer-directed therapy in the next 3 months AND * ECOG Performance Status (0-4) or KPS/Lansky Score (0-100)

Design outcomes

Primary

MeasureTime frameDescription
Test-retest reliabilityup to one monthThe test-retest reliability will be based on the intraclass correlation (ICC) coefficients between the baseline and follow-up domain scores of PRO-AYA.
Linguistically validate PRO-AYA or patients who prefer their healthcare be delivered in Spanish. (Cohort 2)up to a monthThe primary goal of these cognitive interviews is to ensure that the wording and/or phrasing of the instructions, questions and answer choices are appropriate for native Spanish-speakers. The wording and phrasing are a result of direct translation of the English version of the PRO-AYA to a Spanish version.

Countries

United States

Contacts

CONTACTThomas Atkinson, PhD
atkinsot@mskcc.org646-888-0089
CONTACTMarie Barnett, PhD
646-608-8206
PRINCIPAL_INVESTIGATORThomas Atkinson, PhD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026